MedGadget
“Noted journalist and author David Ewing Duncan kicked off the Wednesday session of FutureMed by discussing personalized medicine and his work on the Experimental Man Project.
[ More ]
Ryan McBride, FierceBiotech IT
“Now that the cost of sequencing DNA is quickly plummeting toward $1,000, some scientists in the U.K. are backing a plan to put citizens’ genomic data into a national database.
[ More ]
Paul Cerrato, InformationWeek
“The teaser at the top of a recent Wall Street Journal article proclaimed, “What does the future of medicine hold? Tiny health monitors, tailored therapies–and the end of illness.” Whoa! IT-enhanced personalized medical therapy holds great promise, but we won’t be eliminating disease from the face of the earth any time soon. Nature is much too smart to let that happen.
[ More ]
Masys DR et al, Journal of Biomedical Informatics, 2011
The era of “Personalized Medicine,” guided by individual molecular variation in DNA, RNA, expressed proteins and other forms of high volume molecular data brings new requirements and challenges to the design and implementation of Electronic Health Records (EHRs).
[ More ]
Vinod Khosla, The Crunch
“I was asked about a year ago at a talk about energy what I was doing about the other large social problems, namely health care and education. Surprised, I flippantly responded that the best solution was to get rid of doctors and teachers and let your computers do the work, 24/7 and with consistent quality.
Later, I got to cogitating about what I had said and why, and how embarrassingly wrong that might be. But the more I think about it the more I feel my gut reaction was probably right.
[ More ]
Neil Versel, InformationWeek
“Computer maker Dell is counting on the cloud, analytics, and “big data” to power the future of medicine and make healthcare more personal. The Texas-based hardware giant is putting the infrastructure in place to support electronic health records (EHR) and genomics on the journey from episodic care to coordinated care to personalized medicine.
[ More ]
Chris Gullo, mobihealthnews
“The future of mHealth is bright, according to West Wireless Health Institute vice chairman Eric Topol, who spoke this week at the opening keynote of the 2011 mHealth Summit. “This is a most momentous moment in medicine,” he told the gathered audience.
[ More ]
Hudson KL. N Engl J Med, 365(11)
A new generation of genomic technologies permits the increased collection of data on large study populations. New methods in informatics facilitate the integration of diverse types of information with genomic data in disease research. As a result, researchers are learning more about the genetic bases of disease and response to drugs.
[ More ]
Francine Hardaway, Fast Company
“As the last of the large American industries to undergo forcible automation, healthcare is currently in a state of prolonged agony. The HealthTech NextGen 2011 Conference, held in San Francisco recently, highlighted this by calling attention to at least 6 disruptive changes that are still ahead in healthcare.
[ More ]
Molly Merrill, Healthcare IT News
“Kaiser Permanente and scientists at UCSF are celebrating the first major milestone of their genomics project – they have genotyped the DNA and analyzed the length of chromosome tips in more than 100,000 Kaiser Permanente members. Officials say that their electronic health record played a critical role in helping to achieve this in just 15 months.
[ More ]
Tom Caruso, T.P. Caruso & Associates
“I wonder whether the author of the Healthcare Technology News blog post called “Think Differently – the sequel” thinks that the ONC and their PCAST Workgroup is actually “Thinking Differently”? Though it was a good summary of the PCAST HIT Report and the PCAST Workgroup Report released in mid-April, the blog suggested this was thinking differently. Would Steve Jobs (Mr. Think Differently) say that they are thinking differently? I think not.
[ More ]
Eric Barnes, AuntMinnieEurope.com
“Planning for the era of personalized medicine — a science and an art that combines genetics and patient histories with imaging and population-based atlases — is finally giving way to real treatment of real patients, according to a presentation on the first day of the Computer Assisted Radiology and Surgery (CARS) meeting.
[ More ]
Kohane IS. Nature Reviews. Genetics, 12(6)
If genomic studies are to be a clinically relevant and timely reflection of the relationship between genetics and health status – whether for common or rare variants – cost-effective ways must be found to measure both the genetic variation and the phenotypic characteristics of large populations, including the comprehensive and up-to-date record of their medical treatment.
[ More ]
John, EMR and HIPAA
“I’d been meaning to write about genomics and EMR for a while and so I’m glad that Katherine did. In one of my more interesting discussions at HIMSS with CMO of Nuance, Dr Nick (sorry, his last name is too hard to spell), we talked about the future of EMR and the possible benefits it could provide to patient care, diagnosing, etc. Nuance had partnered with IBM’s Watson project (the famous Jeopardy Watson) to apply the Watson technology to healthcare. At its core is using technology to crunch a lot of data and provide some meaningful (sorry I had to use the word) results or information.
[ More ]
Katherine Rourke, EMR and EHR
“Today I read an interesting blog item making the case for including validated genomic test data into EMRs. The author argues that with the increasing relevance of genomic testing to treatment, it’s critical to offer clinicians access to such data.
[ More ]
Gerry Higgins, HealthSystemCIO
“In some cases, the utility of patient genotyping prior to therapeutics is of unquestioned value. In non-Hodgkin’s and Mantle Cell lymphoma, DNA sequencing of the tumor provides personalized cancer vaccines that demonstrate statistically significant Phase III clinical trial results with disease-free survival benefit in treatment of these types of follicular lymphoma [1].
[ More ]
El Emam K. Genome Medicine, 3(4)
Electronic health records are increasingly being linked to DNA repositories and used as a source of clinical information for genomic research. Privacy legislation in many jurisdictions, and most research ethics boards, require that either personal health information is de-identified or that patient consent or authorization is sought before the data are disclosed for secondary purposes. Here, I discuss how de-identification has been applied in current genomic research projects.
[ More ]
Don Fluckinger, SearchHealthIT
“Halamka, through his participation in the Personal Genome Sequencing Project, discovered his glaucoma far earlier than typical patients do. Knowing his genetic data prompted Halamka to seek care before symptoms developed, which allowed him to take steps to preserve normal vision for the rest of his life.
[ More ]
Turna Ray, Genomeweb
“The day after IBM’s Watson blew away Jeopardy! champions Ken Jennings and Brad Rutter earlier this month, the technology giant announced its intent to apply the computer’s analytical power to providing healthcare solutions.
[ More ]
Ullman-Cullere MH, Mathew JP. Human Mutation, 2011
The Information Technology (IT) roadmap for personalized medicine requires Electronic Health Records (EHRs), extension of Healthcare IT (HIT) standards, and understanding of how genetics/genomics should be integrated into the clinical applications. For reduced overall costs and development times, these three initiatives should run in parallel. EHRs must contain structured data and infrastructure which enables quality analysis, Clinical Decision Support (CDS) and messaging within the healthcare information network. Fortunately, as a result of sustained financial commitment to non-genetic based healthcare, the industry has HIT data standards and understanding of EHR functionality which improves patient safety and outcomes, while reducing overall healthcare costs.
[ More ]
